Abbott Receives FDA Clearance for Use of Femtosecond Laser for Arcuate Incisions

Share on Facebook

Abbott has announced FDA clearance to use its iFS Advanced Femtosecond Laser to create arcuate incisions in corneal surgery, including cataract surgery, according to a news release.

 

The iFS Laser is currently used to create LASIK flaps and other corneal incisions. With the new clearance, the iFS Laser provides surgeons with the ability to make arcuate incisions during surgery.

 

"This is a major advancement and expansion of our femtosecond laser technology," said Jim Mazzo, senior vice president, Abbott Medical Optics, in the release. "Abbott has been a pioneer in the ophthalmic use of femtosecond lasers, and this new use of our technology demonstrates our leadership position in this very dynamic and competitive market. This is an important step as we look to utilize femtosecond laser technology as a potential standard of care during the cataract procedure."

 

Related Articles on FDA Clearances:

CurveBeam Receives FDA 510(k) Approval for the pedCAT 3D Foot and Ankle Scanner

Carestream Health Receives FDA Clearance for Mobile X-Ray System

Sotera Wireless Receives FDA 510(k) Clearance for ViSi Mobile Vital Signs Monitoring System

© Copyright ASC COMMUNICATIONS 2012. Interested in LINKING to or REPRINTING this content? View our policies by clicking here.

 

New from Becker's ASC Review

Bringing Higher Acuity Cases Into ASCs: What is Making this Possible?

Read Now